TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from SBC Medical Group Holdings ( (SBC) ).
On November 13, 2025, SBC Medical Group Co., Ltd., a subsidiary of SBC Medical Group Holdings, announced the commencement of a tender offer to acquire shares of Waqoo, Inc., a Japanese corporation listed on the Tokyo Stock Exchange Growth Market. The tender offer, running from November 14 to December 12, 2025, aims to purchase up to 575,000 shares, with settlement expected on December 19, 2025. This strategic move is part of SBC’s plan to make Waqoo a consolidated subsidiary, enhancing its research and development initiatives and integrating Waqoo’s advanced technologies into SBC’s offerings. This acquisition is expected to strengthen SBC’s competitiveness in clinical areas such as AGA and orthopedics and support the development of new treatment methods and proprietary services.
The most recent analyst rating on (SBC) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on SBC Medical Group Holdings stock, see the SBC Stock Forecast page.
Spark’s Take on SBC Stock
According to Spark, TipRanks’ AI Analyst, SBC is a Neutral.
SBC Medical Group Holdings demonstrates strong financial performance with robust profitability and a solid balance sheet, contributing positively to the overall score. However, technical analysis indicates bearish momentum, which negatively impacts the stock’s attractiveness. The valuation is reasonable, but the lack of a dividend yield may deter some investors. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on SBC stock, click here.
More about SBC Medical Group Holdings
SBC Medical Group Holdings Incorporated is a comprehensive medical group engaged in a wide range of franchise businesses across various medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The company manages a diverse portfolio of clinic brands and is expanding its global presence, particularly in the United States and Asia, through direct operations and medical tourism initiatives.
Average Trading Volume: 51,458
Technical Sentiment Signal: Sell
Current Market Cap: $347.1M
See more insights into SBC stock on TipRanks’ Stock Analysis page.